# Acetylcholine Receptors From Human Muscles as Pharmacological Target for ALS

> **NCT02645461** · NA · COMPLETED · sponsor: **University of Roma La Sapienza** · enrollment: 50 (actual)

## Conditions studied

- Amyotrophic Lateral Sclerosis

## Interventions

- **DRUG:** endocannabinoid palmitoylethanolamide (PEA)
- **DRUG:** Riluzole

## Key facts

- **NCT ID:** NCT02645461
- **Lead sponsor:** University of Roma La Sapienza
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2015-06
- **Final completion:** 2015-12
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2016-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02645461

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02645461, "Acetylcholine Receptors From Human Muscles as Pharmacological Target for ALS". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02645461. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*